These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 773824)

  • 1. Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition.
    Epps DE; Williams RC
    Infect Immun; 1976 Mar; 13(3):741-9. PubMed ID: 773824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of leukocyte chemotaxis by human IgA myeloma components.
    Van Epps DE; Williams RC
    J Exp Med; 1976 Nov; 144(5):1227-42. PubMed ID: 825608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein-mediated neutrophil chemotaxis: a parallel between surface binding and chemotaxis.
    Van Epps DE; Bankhurst AD; Williams RC
    Inflammation; 1977 Jun; 2(2):115-23. PubMed ID: 617803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotoxis of mononuclear cells.
    Ward PA
    J Exp Med; 1968 Nov; 128(5):1201-21. PubMed ID: 5682943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    Ward PA; Becker EL
    J Exp Med; 1968 Apr; 127(4):693-709. PubMed ID: 5642465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human C 1 inhibitor on complement-mediated human leukocyte chemotaxis.
    Smith CW; Hollers JC; Bing DH; Patrick RA
    J Immunol; 1975 Jan; 114(1 Pt 1):216-20. PubMed ID: 1167560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    Snyderman R; Gewurz H; Mergenhagen SE
    J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of leukocyte chemotaxis in alcoholic liver disease.
    Van Epps DE; Strickland RG; Williams RC
    Am J Med; 1975 Aug; 59(2):200-7. PubMed ID: 1080359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.
    Warden GD; Mason AD; Pruitt BA
    Ann Surg; 1975 Mar; 181(3):363-9. PubMed ID: 1093487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotaxis as a preparative technique for human polymorphonuclear leukocytes.
    Van DE; Paxton LL
    J Lab Clin Med; 1975 Aug; 86(2):309-14. PubMed ID: 1097550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic factor inactivator in normal human serum.
    Berenberg JL; Ward PA
    J Clin Invest; 1973 May; 52(5):1200-6. PubMed ID: 4121701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
    Perez HD; Horn JK; Ong R; Goldstein IM
    J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.